Professor, Neuroscience, Mayo Medical School
Psychiatry
Dr. Elliott Richelson, MD
|
|
Give Review
Doctor Elliott Richelson, MD is an expert in the field of Psychiatry. He studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care Doctor Elliott Richelson, MD is a published doctor as well. He has 101 publications published. The latest was: Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the g... He accepts all Medicare patients.
Publications
- A neurotensin analog blocks cocaine-conditioned place preference and reinstatement.
- Elucidating the role of neurotensin in the pathophysiology and management of major mental Disorders.
- Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation.
- Neurotensin agonist attenuates nicotine potentiation to cocaine sensitization.
- Neurotensin agonists in the regulation of food intake.
- Diverse roles of neurotensin agonists in the central nervous system.
- Multi-modality: a new approach for the treatment of major depressive Disorder.
- Review of the histamine system and the clinical effects of H(1) antagonists: Basis for a new model for understanding the effects of insomnia medications.
- NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
- Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action.
- New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations.
- Where are all the novel antidepressants?
- Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia.
- Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties.
- Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats.
- Altering behavioral responses and dopamine transporter protein with antisense peptide nucleic acids.
- A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity.
- Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain.
- Pharmacology of antidepressants.
- Binding of antipsychotic Drugs to human brain receptors focus on newer generation compounds.
- Neurotensin: peptide for the next millennium.
- A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonist.
- A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents.
- Highly potent neurotensin analog that causes hypothermia and antinociception.
- Basic neuropharmacology of antidepressants relevant to the pharmacotherapy of depression.
- Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
- Analysis of binding sites and efficacy of a species-specific peptide at rat and human neurotensin receptors.
- Detection of peptide nucleic acids in tissue extracts of treated animals by gel mobility shift assay.
- In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier.
- Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.
- Receptor pharmacology of neuroleptics: relation to clinical effects.
- Contulakin-G, an O-glycosylated invertebrate neurotensin.
- Pharmacological profile of neuroleptics at human monoamine transporters.
- Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the g...
- Pharmacokinetic interactions of antidepressants.
- Serotonin: and what about its side effects?
- Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception.
- Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
- In vivo studies with low doses of levocabastine and diphenhydramine, but not pyrilamine, antagonize neurotensin-mediated antinociception.
- Mood and cognitive side effects of interferon-alpha therapy.
- Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo.
- Pharmacokinetic Drug interactions of new antidepressants: a review of the effects on the metabolism of other Drugs.
- Muscarinic m4 receptor activation by some atypical antipsychotic Drugs.
- Tetranucleotide repeat polymorphism in the human neurotensin receptor (NT-R) gene.
- The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson''s disease brain.
- Characterization of the genomic structure, promoter region, and a tetranucleotide repeat polymorphism of the human neurotensin receptor gene.
- A method to estimate in vivo D2 receptor occupancy by antipsychotic Drugs.
- Preclinical pharmacology of neuroleptics: focus on new generation compounds.
- The neurotensin receptor: is there more than one subtype?
- Synaptic effects of antidepressants.
- Regulation of neurotensin receptor mRNA expression by the receptor antagonist SR 48692 in the rat midbrain dopaminergic neurons.
- Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).
- Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific, picomolar affinity peptide.
- Sodium nitroprusside-induced apoptotic cellular death via production of hydrogen peroxide in murine neuroblastoma N1E-115 cells.
- Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2.
- A method for radioligand binding assays using a robotic workstation.
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
- Treatment of acute depression.
- Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra.
- Further characterization of neurotensin receptor desensitization and down-regulation in clone N1E-115 neuroblastoma cells.
- Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
- Neurotensin stimulates cyclic AMP formation in CHO-rNTR-10 cells expressing the cloned rat neurotensin receptor.
- Facilitation of adaptation and acute tolerance to stressful sensory input by doxepin and scopolamine plus amphetamine.
- Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and ...
- Identification of a polymorphism in the human neurotensin receptor gene.
- Role of signal transduction systems in neurotensin receptor down-regulation induced by agonist in murine neuroblastoma clone N1E-115 cells.
- Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics.
- Pharmacology of antidepressants--characteristics of the ideal Drug.
- The pharmacology of antidepressants at the synapse: focus on newer compounds.
- Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CH...
- Affinity of neuroleptics for D1 receptor of human brain striatum.
- Binding of antidepressants to human brain receptors: focus on newer generation compounds.
- Inhibition by lithium of cyclic GMP formation without inhibition of nitric oxide generation in the mouse neuroblastoma cell (N1E-115).
- Rational design of novel neurotensin mimetics: discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and f...
- Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study.
- Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson''s disea...
- Bupropion: a review of its mechanism of antidepressant activity.
- Pharmacological and biochemical profiles of unique neurotensin 8-13 analogs exhibiting species selectivity, stereoselectivity, and superagonism.
- Regulation of daily rhythm of body temperature by neurotensin receptor in rats.
- Psychotropic Drugs and histamine H1-receptors of cultured mouse neuroblastoma cells.
- Lithium transport by mouse neuroblastoma cells.
- Pharmacology of antidepressants in use in the United States.
- Perturbation of gastric emptying and duodenal motility through the central nervous system.
- The implications for antidepressant therapy of measurement of urinary MHPG.
- Histamine H1 receptors in the brain and spinal cord of the cat.
- Agonist regulation of muscarinic acetylcholine receptors in rat spinal cord.
- High-affinity binding of [3H]doxepin to histamine H1-receptors in rat brain: possible identification of a subclass of histamine H1-receptors.
- Methionine-enkephalin immunoreactivity in fetal rat brain cells in aggregating culture and in mouse neuroblastoma cells.
- Lanthanum binding to murine neuroblastoma cells.
- Perturbation of upper gastrointestinal function by cold stress.
- Thrombin binding to human brain and spinal cord.
- Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.
- Sodium-dependent lithium ion efflux from murine neuroblastoma and rat glioma cells: a minor pathway for efflux of lithium ions.
- Neurotensin stimulates formation of cyclic GMP in murine neuroblastoma clone N1E-115.
- The coupling of the neuronal muscarinic receptor to responses.
- The newer antidepressants: structures, pharmacokinetics, pharmacodynamics, and proposed mechanisms of action.
- Neurotransmitter receptors mediate cyclic GMP formation by involvement of arachidonic acid and lipoxygenase.
- Antimuscarinic effects of lithium.
- Studying neurotransmitter receptors: binding and biological assays.
- Kinetic effects of terbium ions on muscarinic acetylcholine receptors of murine neuroblastoma cells.
Schools
Johns Hopkins University School Of Medicine
Barnes Hospital Wash
Johns Hopkins Hospital
Procedures Preformed
- Psychiatric Evaluation
- Psychological Testing
Conditions Treated
- Anxiety
- Bipolar Disorder
- Major Depressive Disorder
- Nondependent Alcohol Abuse
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Johns Hopkins University -
Washington University - Barnes-Jewish Hospital -
Johns Hopkins University School of Medicine
Hospital
-
Mayo Clinic - Jacksonville, Florida
Drug Facts
| NPI NUMBER | 1124018056 | |
| NPPES Provider LastName | RICHELSON | |
| NPPES Provider FirstName | ELLIOTT | |
| NPPES Provider ZIPCode | 322241865 | |
| NPPES Provider State | FL | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 261.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124018056 |
| Last Name Of The Provider | RICHELSON |
| First Name Of The Provider | ELLIOTT |
| View All |
Similar Doctors
|
Dr. Amit K. Vijapura, MD |
|
|
Dr. Henry Lepely, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Joyce, MD |
|
|
Dr. Mohamed O. Saleh, MD |
|
|
Dr. Gamze Balci Camsari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debabrata Saha, MD
This Doctor is OpenDoctor Recommended.
|